| URL | https://www.wsj.com/articles/the-tax-law-just-one- |
| Source | The Wall Street Journal |
| Date Published | 01/25/2018 |
| Author Name | Theo Francis |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Amicus Therapeutics |
| Parent company | Amicus Therapeutics |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 200 |
| Capital investment ($): | 200 |
| Country(ies) from which reshored: | United States |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | bio pharmaceuticals |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Government Incentives, Infrastructure (transport, internet, power), Proximity to customers/market, Skilled workforce availability/training |